FGF-23 protein is present in normal plasma and is increased in patients with tumor-induced osteomalacia.

被引：0
|
作者：
Yamazaki, Y
Shibata, M
Okazaki, R
Takeuchi, Y
Fujita, T
Yamashita, T
Fukumoto, S
机构：
[1] Kirin Brewery Co Ltd, Pharmaceut Res Labs, Takasaki, Gumma, Japan
[2] Teikyo Univ, Dept Med, Ichihara, Japan
[3] Univ Tokyo, Sch Med, Dept Med, Tokyo 113, Japan
[4] Tokyo Univ Hosp, Dept Lab Med, Tokyo 113, Japan
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2002年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1143
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [1] Cinacalcet is associated with decreased serum FGF-23 and improved phosphorous homeostasis in patients with tumor-induced osteomalacia.
    Geller, JL
    Cutler, C
    Kelly, MH
    Adams, JS
    Collins, MT
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S177 - S177
  • [2] TUMOR-INDUCED OSTEOMALACIA CAUSED BY A FGF-23 PRODUCING MESENCHYMAL TUMOR
    Hu, Sophia
    Lubitz, Sara
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2014, 29 : S460 - S460
  • [3] Tumor-Induced Osteomalacia: Increased Level of FGF-23 in a Patient with a Phosphaturic Mesenchymal Tumor at the Tibia Expressing Periostin
    Hautmann, Anke H.
    Schroeder, Josef
    Wild, Peter
    Hautmann, Matthias G.
    Huber, Elisabeth
    Hoffstetter, Patrick
    Fleck, Martin
    Girlich, Christiane
    [J]. CASE REPORTS IN ENDOCRINOLOGY, 2014, 2014
  • [4] FGF-23, FGF-7, sFRP-4, and MEPE expression in tumor induced osteomalacia.
    Habra, MA
    Huang, SE
    Cote, GJ
    Murphy, WA
    Katz, RL
    Gagel, RF
    Klein, MJ
    Hoff, AO
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S344 - S344
  • [5] Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia.
    Larsson, T
    Zahradnik, R
    Marsell, R
    Ljunggren, Ö
    Lavigne, J
    Jueppner, H
    Jonsson, K
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2002, 17 : S279 - S279
  • [6] A Normal FGF23 Does Not Preclude Tumor-Induced Osteomalacia
    Nandam, Neeharika
    Ejaz, Sadia
    Ahrens, William
    Styner, Maya
    [J]. JBMR PLUS, 2021, 5 (02)
  • [7] Tumor-induced osteomalacia: increased level of FGF-23 in a patient with a mesenchymal giant cell tumor at the tibia expressing Periostin
    Hautmann, A. H.
    Schroeder, J.
    Wild, P.
    Hautmann, M.
    Hoffstetter, P.
    Girlich, C.
    Fleck, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 156 - 157
  • [8] TUMOR-INDUCED OSTEOMALACIA (TIO) WITH ELEVATED FGF-23 CAUSING HYPOPHOSPHATEMIA IN OVARIAN MALIGNANCY
    Paster, L.
    Mastroianni, F.
    Ross, D.
    Feldhamer, K.
    Wanchoo, R.
    Jhaveri, K. D.
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (04) : A65 - A65
  • [9] Sensitivity of FGF23 measurements in tumor induced osteomalacia.
    Imel, EA
    Peacock, M
    Pitukcheewanont, P
    Heller, HJ
    Ward, LM
    Shulman, D
    Kassem, M
    Rackoff, P
    Zimering, M
    Dalkin, A
    Drobney, E
    Colussi, G
    Shaker, J
    Hoogendorn, EH
    Econs, MJ
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S178 - S178
  • [10] Multimodality Diagnosis and Treatment of Tumor-Induced Osteomalacia.
    Andreopoulou, P.
    Millo, C. M.
    Reynolds, J. C.
    Kelly, M. H.
    Brillante, B. A.
    Wodajo, F. M.
    Chang, R.
    Chen, C. C.
    Collins, M. T.
    [J]. ENDOCRINE REVIEWS, 2010, 31 (03) : S49 - S49
12345